EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (4)
2022
-
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
European Journal of Cancer, Vol. 175, pp. 110-119
2019
-
Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study
Cancer Chemotherapy and Pharmacology, Vol. 84, Núm. 4, pp. 781-789
2015
2011
-
Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients
Expert Opinion on Pharmacotherapy, Vol. 12, Núm. 16, pp. 2433-2439